![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 22, 2016 12:14:45 PM
So, company seems to have derived a "7 Day Trial" campaign, very clever, to move the product by essentially giving to sales channels.
That thought has crossed my mind. Seems like a bunch of Actipatches are showing up in markets where it is legal to sell. It is better for Biel to recoup some of the cost over lose all of the cost. I also tend to believe Oxford was given a bunch of the same near end of life products to run the trial in hopes that a few would experience results. Could be they were expired units that are questionable with regards to working batteries. You would get the placebo effect. Some hypochondriacs would claim they worked wonders when the actually did nothing. It is all smoke and mirrors to sell stock anyway.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM